Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05825001

Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers

Pilot Study of Episodic Future Thinking Among Cigarette Smokers

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
104 (actual)
Sponsor
Roswell Park Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical trial evaluates the effectiveness of active episodic future thinking (EFT) stimuli for reducing cigarette consumption in cigarette smokers. EFT is an innovative framing method shown to significantly activate brain regions involved in future thinking, planning, and other executive functions. Active EFT stimuli are positive events, unrelated to smoking, that participants anticipate, look forward to, and can vividly imagine happening up to 1 year in the future. Control EFT stimuli are positive past events, unrelated to smoking, that participants can vividly remember happening in the recent past. Active EFT stimuli may help reduce cigarette consumption among cigarette smokers by exposing them to personally relevant future oriented stimuli.

Detailed description

PRIMARY OBJEECTIVE: I. To evaluate the efficacy of episodic future thinking (EFT) for smoking cessation. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I (ACTIVE): Participants receive the active EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor on study. ARM II (CONTROL): Participants receive the control EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor on study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSmoking Cessation InterventionReceive active EFT stimulus
BEHAVIORALSmoking Cessation Intervention (control)Receive control EFT stimulus
OTHERMedical Device Usage and EvaluationUse iCOquit Smokerlyzer carbon monoxide monitor

Timeline

Start date
2024-09-15
Primary completion
2025-10-01
Completion
2026-10-01
First posted
2023-04-24
Last updated
2026-02-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05825001. Inclusion in this directory is not an endorsement.